拉米夫定治疗慢性乙型肝炎的临床研究  

Clinical study of treatment for chronic hepatitis B with lamivudine

作　　者：邹海殊 张文超 蒋广华 金宝胜 陈雁南[2] 徐文波 

机构地区：[1]解放军第465医院,吉林市132013 [2]吉林市中心医院,吉林市132013

出　　处：《空军医高专学报》1999年第2期101-103,共3页

摘　　要：笔者观察了拉米夫定治疗慢性乙型肝炎的临床疗效,并与病毒唑进行对照比较.结果表明,口服拉米夫定100mg/d,可明显抑制乙型肝炎病毒的复制,表现为HBV-DNA、HBeAg转阴及ALT下降,疗效明显优于病毒唑.Clinical effects of the treatment for chronic hepatitis B with lamivudine were observed and compared with the effects with virazole. The result showed that daily dose of lamivudine could restrict the replication of HBV obviously, with HBV-DNA and BHeAg turning negative and ALT declining. The curative effect of lamivudine was better than that of virazole

关 键 词：拉米夫定 慢性 乙型肝炎 病毒 

分 类 号：R512.62[医药卫生—内科学]